Tralonide: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|A synthetic glucocorticoid corticosteroid}} | |||
{{Drugbox | |||
| verifiedfields = changed | |||
| verifiedrevid = 477241123 | |||
| image = Tralonide.svg | |||
| image_size = 200px | |||
}} | |||
'''Tralonide''' is a synthetic [[glucocorticoid]] [[corticosteroid]] used in the treatment of various inflammatory and allergic conditions. It is a potent anti-inflammatory agent that works by suppressing the immune response and reducing inflammation. | |||
Tralonide | ==Pharmacology== | ||
Tralonide is classified as a glucocorticoid, which is a type of corticosteroid. Glucocorticoids are known for their ability to modulate the immune system and decrease inflammation. They achieve this by binding to the glucocorticoid receptor, which then translocates to the cell nucleus and influences the transcription of anti-inflammatory proteins while repressing the transcription of pro-inflammatory proteins. | |||
== | ==Medical uses== | ||
Tralonide is primarily used in the management of conditions that involve inflammation and overactive immune responses. These conditions include, but are not limited to, [[asthma]], [[allergic rhinitis]], and various [[dermatitis|dermatological]] conditions. It is often administered topically or via inhalation to target specific areas of inflammation. | |||
==Side effects== | |||
As with other corticosteroids, the use of tralonide can lead to side effects, especially with long-term use. Common side effects include skin thinning, increased risk of infection, and potential suppression of the [[hypothalamic-pituitary-adrenal axis]]. Patients are advised to use the lowest effective dose for the shortest duration possible to minimize these risks. | |||
== | ==Mechanism of action== | ||
Tralonide exerts its effects by binding to the glucocorticoid receptor, which is present in almost every cell in the body. Upon binding, the receptor-ligand complex translocates to the cell nucleus, where it binds to glucocorticoid response elements in the DNA. This binding alters the transcription of various genes, leading to an increase in the production of anti-inflammatory proteins and a decrease in the production of pro-inflammatory cytokines. | |||
==History== | |||
Tralonide was developed as part of efforts to create more effective and targeted anti-inflammatory medications. Its development was driven by the need for corticosteroids that could be used topically or via inhalation to reduce systemic side effects. | |||
== | ==Related pages== | ||
* [[Corticosteroid]] | |||
* [[Glucocorticoid]] | |||
* [[Anti-inflammatory]] | |||
==References== | |||
{{Reflist}} | |||
[[Category:Glucocorticoids]] | |||
[[Category:Corticosteroids]] | |||
[[Category: | |||
[[Category: | |||
Revision as of 19:59, 8 February 2025
A synthetic glucocorticoid corticosteroid
| Tralonide | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Tralonide is a synthetic glucocorticoid corticosteroid used in the treatment of various inflammatory and allergic conditions. It is a potent anti-inflammatory agent that works by suppressing the immune response and reducing inflammation.
Pharmacology
Tralonide is classified as a glucocorticoid, which is a type of corticosteroid. Glucocorticoids are known for their ability to modulate the immune system and decrease inflammation. They achieve this by binding to the glucocorticoid receptor, which then translocates to the cell nucleus and influences the transcription of anti-inflammatory proteins while repressing the transcription of pro-inflammatory proteins.
Medical uses
Tralonide is primarily used in the management of conditions that involve inflammation and overactive immune responses. These conditions include, but are not limited to, asthma, allergic rhinitis, and various dermatological conditions. It is often administered topically or via inhalation to target specific areas of inflammation.
Side effects
As with other corticosteroids, the use of tralonide can lead to side effects, especially with long-term use. Common side effects include skin thinning, increased risk of infection, and potential suppression of the hypothalamic-pituitary-adrenal axis. Patients are advised to use the lowest effective dose for the shortest duration possible to minimize these risks.
Mechanism of action
Tralonide exerts its effects by binding to the glucocorticoid receptor, which is present in almost every cell in the body. Upon binding, the receptor-ligand complex translocates to the cell nucleus, where it binds to glucocorticoid response elements in the DNA. This binding alters the transcription of various genes, leading to an increase in the production of anti-inflammatory proteins and a decrease in the production of pro-inflammatory cytokines.
History
Tralonide was developed as part of efforts to create more effective and targeted anti-inflammatory medications. Its development was driven by the need for corticosteroids that could be used topically or via inhalation to reduce systemic side effects.
Related pages
References
<references group="" responsive="1"></references>
